FierceBiotech ٢٤ أبريل ٢٠٢٦ After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?
FierceBiotech ٢٢ أبريل ٢٠٢٦ Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
FierceBiotech ٧ أبريل ٢٠٢٦ Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
FierceBiotech ٣١ مارس ٢٠٢٦ Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
FierceBiotech ٢٣ مارس ٢٠٢٦ Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
FierceBiotech ١٩ مارس ٢٠٢٦ Lilly's obesity discovery partner Fauna sees weight loss potential in hibernating mammals
FierceBiotech ١٩ مارس ٢٠٢٦ Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech ٩ فبراير ٢٠٢٦ Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech ٤ فبراير ٢٠٢٦ Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
FierceBiotech ٢٩ يناير ٢٠٢٦ Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
FierceBiotech ٢٨ يناير ٢٠٢٦ Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech ١٢ يناير ٢٠٢٦ JPM26, Day 1: Stock market titans Lilly, Nvidia expand team-up with AI co-innovation lab
FierceBiotech ١٢ يناير ٢٠٢٦ Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
FierceBiotech ٨ يناير ٢٠٢٦ Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
FierceBiotech ١١ ديسمبر ٢٠٢٥ Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
FierceBiotech ٨ ديسمبر ٢٠٢٥ With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec